CPB vs RNAC · P/E 12, rev $10.25B vs P/E 2.1, rev $38.9M
Campbell’s Co (CPB) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the CPB and RNAC stock pages for the full models.
Not investment advice.